Olli-Veikko Renkonen
- Epidemiology top 5%
- Microbiology top 0.5%
- Periodontics top 1%
- Public Health, Environmental and Occupational Health top 10%
- Infectious Diseases
- Co-authors
- Satu AlaluusuaKaarina SivonenHeikki PeltolaP. Helena MäkeläHelena KäyhtyVille ValtonenTHE PARA STUDY GROUPM Anttila
- Topics
- Pneumonia and Respiratory Infections (7 papers)Antibiotics Pharmacokinetics and Efficacy (6 papers)Bacterial Infections and Vaccines (5 papers)
- Cited by
- MicrobiologyPeriodonticsEpidemiology
- Partner nations
- FinlandUnited Kingdom
In The Last Decade
Olli-Veikko Renkonen
23 papers receiving 941 citations
Peers
Comparison fields: 5 of 86
- Epidemiology 602
- Microbiology 496
- Periodontics 227
- Public Health, Environmental and Occupational Health 206
- Infectious Diseases 103
Countries citing papers authored by Olli-Veikko Renkonen
This map shows the geographic impact of Olli-Veikko Renkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olli-Veikko Renkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olli-Veikko Renkonen more than expected).
Fields of papers citing papers by Olli-Veikko Renkonen
This network shows the impact of papers produced by Olli-Veikko Renkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olli-Veikko Renkonen. The network helps show where Olli-Veikko Renkonen may publish in the future.
Co-authorship network of co-authors of Olli-Veikko Renkonen
This figure shows the co-authorship network connecting the top 25 collaborators of Olli-Veikko Renkonen. A scholar is included among the top collaborators of Olli-Veikko Renkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olli-Veikko Renkonen. Olli-Veikko Renkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 18 | |
| 3 | 9 | |
| 4 | 19 | |
| 5 | 22 | |
| 6 | 19 | |
| 7 | 55 | |
| 8 | 4 | |
| 9 | 22 | |
| 10 | 4 | |
| 11 | 120 | |
| 12 | 11 | |
| 13 | 65 | |
| 14 | 16 | |
| 15 | 9 | |
| 16 | 7 | |
| 17 | 3 | |
| 18 | 250 | |
| 19 | 273 | |
| 20 | 95 |
About Olli-Veikko Renkonen
Olli-Veikko Renkonen is a scholar working on Endocrinology, Microbiology and Molecular Medicine, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Bacterial Infections and Vaccines (5 papers). The work is most often cited by research in Microbiology (496 citations), Periodontics (227 citations) and Epidemiology (602 citations). Olli-Veikko Renkonen has collaborated with scholars based in Finland and United Kingdom. Frequent co-authors include Satu Alaluusua, Kaarina Sivonen, Heikki Peltola, P. Helena Mäkelä, Helena Käyhty, Ville Valtonen, THE PARA STUDY GROUP, M Anttila, O Pettay and P Ahvonen. Their work appears in journals such as New England Journal of Medicine, The Lancet and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.